Abstract In addition to preventing tissue energy loss during cardiopulmonary bypass, pentoxifylline (Ptx) prevents the production of pro-inflammatory cytokines as well.The aim of this study was to investigate whether Ptx decreases the inflammatory effects of cardiopulmonary bypass on the lungs during open-heart surgery. The patients in the study group (n=15) who were going through an open-heart surgery had 500 mgl À1 of Ptx added to their prime solution, whereas the patients in the control group (n=10) only received prime solution.Pre-pump and post-pump blood samples were obtained from both groups and assayed for interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor alpha (TNFa).Lung tissue samples that were obtained after the pump were examined with light microscopy and stained for tissueTNFa.Non-parametric Wilcoxon test was utilized for statistical evaluation.In the post-pump period, the difference in the IL-6, IL-8 and TNFa levels of the two groups was found to be statistically significant (Po0?005). The tissue samples from the control group had significant staining withTNFa.. We think that Ptx has important protective effects on the lungs during cardiopulmonary bypass.r 2002
INTRODUCTION
During cardiopulmonary bypass the lungs are exposed to several types of insults such as ischaemia^reper-fusion injury, in£ammatory responses and re-expansion injury (1) . These factors interact in an attempt to increase each other's damaging capacity, and tissue injury occurs as a result of a complex metabolic chain of events. Pentoxifylline (Ptx) avoids dephosphorylazation of adenosine monophospate (AMP) to adenosine and inosine monoposphate (IMP) to inosine via inhibition of 5 0 -nucleotidase (5 0 -NT) and exterminate these precursors from cell during cardiopulmonary bypass.*Ptx also inhibits the production of pro-in£ammatory cytokines and have anti-in£ammatory properties. Ptx decreases tissue injury by exerting its e¡ect at di¡erent steps of this metabolic chain (2) . Our aim was to investigate these e¡ects of Ptx on lungs during cardiopulmonary bypass.
MATERIALS AND METHOD
The study was conducted on the patients who had gone through open-heart surgery in our department between December 1999^May 2000 with the authority of the Board of Ethics of the Gaziantep University Medical Faculty Hospital issued as of 9 June 1999 and after their written consents were obtained. According to demographic data, the patients were blindly divided into two subgroups. Both groups had approximately the same average age, diagnosis and female^male ratio. The surgeon, the biochemist and the pathologist were blind to the grouping The average age of the patients in the study group (n=15) was 36?5 yrs, the female to male ratio was 2/1 and their diagnoses were valvular heart disease (n=13), atrial septal defect (ASD) (n=1) and ventricular septal defect (n=1). Control group patients (n=10) had an average age of 34?4 yrs, female to male ratio of 3/2 and their diagnoses were valvular heart disease (n=7), ASD (n=1) and VSD (n=2).
All the patients received intravenous anesthesia with fentanyl (10 mg kg ) and Vecuronium (0?1mg kg À1 induction, 0?05 mg kg À1 maintenance).
The average duration of pumping was 125 min for the study group and 110 min for the control group. The average duration of cross-clamp was calculated as 85 min for the study group and 80 min for the control group. Standard prime solutions that consisted of ringer lactate, NaHCO 3 (1mg kg ) and antibiotics were used in the control group. Five hundred mg l À1 Ptx was added to the prime solution for the study group (2, 3) .
According to the preliminary study results, prepump and post-pump left atrium blood samples were collected from both groups and interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor alpha (TNFa) levels were determined with chemiluminescence enzyme immunometric assays on an Immulite immunoassay analyser (Immulite IL-6, IL-8, TNFa assays, DPC, Los Angeles, CA, USA). In these assays the chemiluminescent substrate, a phosphate ester of adamantyl dioxetane, undergoes hydrolysis in the presence of alkaline phosphatase resulting in the sustained emission of light.
The analytical sensitivity of the IL-6, IL-8 and TNFa assays were 1pg ml À1 , 2 pgml À1 and 1.7 pg ml À1 and the lower reportable ranges were 5 pg ml À1 , 5pgml À1 and 4 pg ml À1 respectively. Control sera ILCO 10009 and ILC0 20009 were included in each analytic run. Intraassay and interassay precision performances of the assays that were determined on 10 replicates in a single run and 20 di¡erent runs, respectively, yielded coe⁄-cients of variation within 3?4^8?8% at 13?3 and 31?4 pgml À1 concentrations for IL-6, at 117?0 and 584?0 pgml À1 concentrations for IL-8 and at 65.0 and 281?0 pgml À1 concentrations for TNFa. The lung tissue samples that were obtained after the pump were stained for tissueTNFa with immunohystochemical streptavidin^biotin method. Five-micron tissue sections were placed on the adhesive slides (poly-L-lysine, Sigma no P 8920) and microwaved with antigen retrieval solution for 10 min. The monoclonal antibodies toTNFa (Neomarkers MS1073,USA) was used for immunohistochemical staining of the sections. Streptavidinb iotin, horseradish peroxidase method (DAKO, LSAB 2, K 0675) and DAB chromogene was used for immunohistochemical staining. The sections were washed with phosphate-bu¡ered saline (PBS) to prevent drying. Finally Mayer's haematoxylin was used as counterstain.
To control the lung tissues stained, we used the tonsil tissue macrophages that were recommended on the data sheet of Neomarkers MS 1073, and also transsuced the antigen retrieval solutions at the same time as the lung preparations.
We observed light and dark brown areas in the stoplasmic tonsil tissue macrophages and the lung tissue at the light microscopic examination. The brown area contained tissueTNFa and the nuclei were stained blue and violet.
For the statistical comparison of the data that were obtained from both groups, the non-parametric Wilcoxon test was utilized.
RESULTS
In the left atrium blood samples that were obtained before the pump, mean IL-6, IL-8 and TNFa values did not show any signi¢cant di¡erence between the two groups (P40?05) ( Table 1 , Fig. 1 ). In the left atrium blood samples that were obtained after the pump, mean IL-6, IL-8 and TNFa values showed signi¢-cant di¡erences between the two groups (Po0?005) ( Table 1 , Fig.1 ).
In the control group, the tissue samples had signi¢-cant staining for TNFa, whereas there was only mild accumulation of tissue TNFa in the study group (Figs 2  and 3 ).
DISCUSSION
During a cardiopulmonary bypass operation, the metabolites that are produced as result of in£ammation and ischaemia^reperfusion injury damage the lung tissue. With the activation of 5 0 nucleotidase enzyme in the tissue's ischaemia phase, ATP is converted to AMP and IMP, adenosine, inosine and hypoxanthine. 
Meanwhile, Ca
2+ accumulates within the cell due the altered ion balance. During the reperfusion period, the reaction of hypoxanthine with the accumulated Ca 2+ results in the formation of reactive oxygen metabolites within the cell (4). Reperfusion of the ischaemic tissue increases the concentrations of chemotactic factors such as lipid mediators, polypeptide mediators and immune complexes (5, 6) . Chemotactic factors attract monocytes, polymorphonuclear leukocytes (PNL) and macrophages to the environment.
The lung is one of the largest reservoirs for monocytes, macrophages and PNLs. During cardiopulmonary bypass, in addition to ischaemia^reperfusion injury, an in£ammatory reaction occurs as a result of PNL accumulation in the lungs.The PNLs that migrate to the tissue as a result of the in£ammatory process initiates the tissue damage by triggering several reactions (7) .
PNLs that accumulate in the tissue secrete myeloperoxidase, which produces hydroxychloride (HOCl). HOCl has a direct cytotoxic e¡ect and, by inactivating a 1-protease inhibitor, it participates in the production of collagenases and elastases from the PNLs (8^10).
The PNLs that are in the environment, favour the secretion of pro-in£amatory cytokines such as IL-6, IL-8 and TNFa (11) .
Ptx has been reported to inhibit the production of pro-in£ammatory cytokines and to have anti-in£amma-tory properties. It protects the mitochondria structures of the cell at the same time (12) .
Animal and human myocardial studies have demonstrated that newborn myocardium had higher resistance to ischaemia. This ¢nding is supported by the low levels of 5 0 nucleotidase activity in the myocardium of the newborns (13) .
Ptx exerts its e¡ect by inhibiting the activity of 5 0 nucleotidase enzyme. It prevents the evolution of future metabolic chains that have potential hazards while preserving the energy stores which will be required at the time of reperfusion. This shows us that Ptx could be used during cardiopulmonary bypass to protect the myocardium (2,11,13^15).
The reaction that occurs during cardiopulmonary bypass is not limited to the myocardium, but can a¡ect other organs of the body as well. As a result of this, peripheral organ systems including the lungs can be harmed to varying degrees (1, 13, 16) .
In order to evaluate the protective e¡ect of Ptx the present study determined the IL-6, IL-8 and TNFa levels in blood samples obtained from the left atrium and TNFa stain was performed at the tissue level.
In anin vivo study performed byYoshiki et al. (14) in parallel to the in£ammation that occurred during the ischaemia, the levels of IL-6, IL-8 and blood TNFa increased as a result of the activation of PNLs and monocytes and macrophages were reported. In the same study, with the administration of Ptx, IL-6, IL-8 and blood TNFa levels decreased when compared to those of the control group. The results of Cain et al. also supported these ¢ndings (15) .
In the present study, if the levels of IL-6, IL-8 and TNFa are analyzed, there is a statistically signi¢cant di¡erence between the two groups. In the light of this observation, we think that the tissue in£ammatory response and ischaemia^reperfusion damage has been reduced to a great extent in the control group patients.
In the study byTˇrk˛z et al., it was reported that Ptx, by inhibiting the PNL activation in the lungs, prevented the accumulation of the cells, thereby reducing the damage to the lungs (17). Kleinschmidt et al. stated that Ptx could decrease endothelial damage and permeability (1) .
TNFa, which is a pro-in£ammatory cytokine, can accumulate in the tissue as well as being released to the circulation.The tissue staining forTNFa was minimal in the study group, whereas the control group showed a great degree of staining. According to the evidence collected from the biochemical and microscopic data, the tissue in£ammatory response and ischaemia-reperfusion injury was signi¢-cantly diminished in the study group.
In conclusion, in the light of the results we have obtained, we think that Ptx can play an important role in the prevention of lung damage that can occur during cardiopulmonary bypass.
FIG. 2.
Increased levels of TNFa, meant that expanded brown areas were visualized in the alveolar wall of control group samples (Immunohistochemistry, X200).
FIG. 3.
In the alveolar wall of study group samples, small brown areas were visualized (Immunohistochemistry, X200).
